210 related articles for article (PubMed ID: 31625563)
1. Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models.
Liang C; Shao Q; Zhang W; Yang M; Chang Q; Chen R; Chen JF
Hum Mol Genet; 2019 Dec; 28(23):3940-3953. PubMed ID: 31625563
[TBL] [Abstract][Full Text] [Related]
2.
Shao Q; Yang M; Liang C; Ma L; Zhang W; Jiang Z; Luo J; Lee JK; Liang C; Chen JF
Autophagy; 2020 Sep; 16(9):1635-1650. PubMed ID: 31847700
[TBL] [Abstract][Full Text] [Related]
3. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Beckers J; Tharkeshwar AK; Van Damme P
Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
[TBL] [Abstract][Full Text] [Related]
4. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy.
Yang M; Liang C; Swaminathan K; Herrlinger S; Lai F; Shiekhattar R; Chen JF
Sci Adv; 2016 Sep; 2(9):e1601167. PubMed ID: 27617292
[TBL] [Abstract][Full Text] [Related]
5. Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD.
Su MY; Fromm SA; Zoncu R; Hurley JH
Nature; 2020 Sep; 585(7824):251-255. PubMed ID: 32848248
[TBL] [Abstract][Full Text] [Related]
6. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
7. SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasis.
Lan Y; Sullivan PM; Hu F
Autophagy; 2019 May; 15(5):871-885. PubMed ID: 30696333
[TBL] [Abstract][Full Text] [Related]
8. Structure of the human C9orf72-SMCR8 complex reveals a multivalent protein interaction architecture.
Nörpel J; Cavadini S; Schenk AD; Graff-Meyer A; Hess D; Seebacher J; Chao JA; Bhaskar V
PLoS Biol; 2021 Jul; 19(7):e3001344. PubMed ID: 34297726
[TBL] [Abstract][Full Text] [Related]
9. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mäger I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
Brain; 2017 Apr; 140(4):887-897. PubMed ID: 28334866
[TBL] [Abstract][Full Text] [Related]
10. Reversing lysosome-ribosome circuit dysregulation mitigates C9FTD/ALS neurodegeneration and behaviors.
Ma L; Liang C; Wang J; Chang Q; Wang Y; Zhang W; Du Y; Sadan J; Chen JF
Hum Mol Genet; 2023 Apr; 32(8):1252-1265. PubMed ID: 36322143
[TBL] [Abstract][Full Text] [Related]
11. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
[TBL] [Abstract][Full Text] [Related]
12. C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner.
Shao Q; Liang C; Chang Q; Zhang W; Yang M; Chen JF
Acta Neuropathol Commun; 2019 Mar; 7(1):32. PubMed ID: 30832726
[No Abstract] [Full Text] [Related]
13. Systemic deregulation of autophagy upon loss of ALS- and FTD-linked C9orf72.
Ji YJ; Ugolino J; Brady NR; Hamacher-Brady A; Wang J
Autophagy; 2017 Jul; 13(7):1254-1255. PubMed ID: 28319438
[TBL] [Abstract][Full Text] [Related]
14. The progress in
Jiang L; Zhang T; Lu K; Qi S
Small GTPases; 2022 Jan; 13(1):56-76. PubMed ID: 33663328
[TBL] [Abstract][Full Text] [Related]
15. An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD.
Bauer CS; Cohen RN; Sironi F; Livesey MR; Gillingwater TH; Highley JR; Fillingham DJ; Coldicott I; Smith EF; Gibson YB; Webster CP; Grierson AJ; Bendotti C; De Vos KJ
Acta Neuropathol; 2022 Sep; 144(3):437-464. PubMed ID: 35876881
[TBL] [Abstract][Full Text] [Related]
16. Cellular and physiological functions of C9ORF72 and implications for ALS/FTD.
Pang W; Hu F
J Neurochem; 2021 May; 157(3):334-350. PubMed ID: 33259633
[TBL] [Abstract][Full Text] [Related]
17. Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models.
Liang C; Shao Q; Zhang W; Yang M; Chang Q; Chen R; Chen JF
Hum Mol Genet; 2020 Apr; 29(6):1056. PubMed ID: 32057072
[No Abstract] [Full Text] [Related]
18. Loss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation.
Bauer CS; Webster CP; Shaw AC; Kok JR; Castelli LM; Lin YH; Smith EF; Illanes-Álvarez F; Higginbottom A; Shaw PJ; Azzouz M; Ferraiuolo L; Hautbergue GM; Grierson AJ; De Vos KJ
Front Cell Neurosci; 2022; 16():1061559. PubMed ID: 36619668
[TBL] [Abstract][Full Text] [Related]
19. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy.
Webster CP; Smith EF; Bauer CS; Moller A; Hautbergue GM; Ferraiuolo L; Myszczynska MA; Higginbottom A; Walsh MJ; Whitworth AJ; Kaspar BK; Meyer K; Shaw PJ; Grierson AJ; De Vos KJ
EMBO J; 2016 Aug; 35(15):1656-76. PubMed ID: 27334615
[TBL] [Abstract][Full Text] [Related]
20. The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis.
Zhang Y; Burberry A; Wang JY; Sandoe J; Ghosh S; Udeshi ND; Svinkina T; Mordes DA; Mok J; Charlton M; Li QZ; Carr SA; Eggan K
Genes Dev; 2018 Jul; 32(13-14):929-943. PubMed ID: 29950492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
